Skip to content

Karuna Therapeutics, Inc.

CIK 0001771917

← back to feed
Revenue (TTM)
$735K
−93.9% YoY FY Mar 2024
Net Income (TTM)
−$396.82M
−56.9% YoY FY Mar 2024
EPS Diluted (TTM)
−$11.09
−34.2% YoY FY Mar 2024
Gross Margin
—
FY Mar 2024
Operating Margin
-60,705.4%
FY Mar 2024
Net Margin
-53,989.0%
FY Mar 2024
Free Cash Flow (TTM)
−$180.79M
FY Mar 2024
Cash
$185.82M
FY Mar 2024
Total Debt
—
FY Mar 2024
Shares Outstanding
38.2M sh
FY Mar 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings